GlassScriptPhysician profile
Irvin Jay Seeman
NPI 1962499871
$628.98
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $549 · 2020: $64.19 · 2022: $16.18.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $123.79 | 2019-2020 | |
| Pfizer INC. | $122.72 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $70.74 | 2019 | |
| Abbvie INC. | $64.09 | 2019 | |
| Intercept Pharmaceuticals, INC. | $43.94 | 2019-2020 | |
| Daiichi Sankyo INC. | $40.11 | 2019 | |
| Shire North American Group INC | $37.51 | 2019 | |
| Genzyme Corporation | $24.97 | 2019 | |
| Shionogi INC | $24.70 | 2019 | |
| Qol Medical, LLC | $24.64 | 2019-2020 | |
| Ucb, INC. | $24.48 | 2019 | |
| Bioventus LLC | $16.18 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.11 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irvin Seeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.